Zachary Buchwald, MD
Enriched profileAssociate Professor, Department of Radiation Oncology, Emory University School of Medicine · Emory University School of Medicine
Zachary Buchwald is Associate Professor, Department of Radiation Oncology, Emory University School of Medicine at Emory University School of Medicine. OpenAlex indexes 115 publications with 2,727 citations (h-index 27); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 3 Nov 2026
Overview
Updated 3 Nov 2026
Zachary Buchwald, M.D. PH.D., is Associate Professor, Department of Radiation Oncology, Emory University School of Medicine. The public record shows 115 publications with 2,727 citations (h-index 27), centered on Cancer Immunotherapy and Biomarkers, T-cell and B-cell Immunology, Immunotherapy and Immune Responses. It also documents an investigator role on 1 registered clinical trials, 2 NIH-funded awards (2023–2026).
- Most recent indexed publication: 2025 · Nature communications
- Top research focus: Cancer Immunotherapy and Biomarkers
- 1 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 3 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 6 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 42.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 3 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Radiosurgery Before Surgery for the Treatment of Brain Metastases
Sponsor: Emory University
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Opioid Agonist100%Oxycodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 3 Nov 2026
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Exploiting SAMHD1 in Directing Radiation and Immunologic Dynamics
Emory University
FY2026$645,949R01CA301614 - Exploiting SAMHD1 in Directing Radiation and Immunologic Dynamics
Emory University
FY2025$645,949R01CA301614
Congress activity
Updated 3 Nov 2026
32 congress contributions (2015–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract LB230: A prospective immunological analysis of head and neck squamous cell carcinoma in humans
AACR Annual Meeting
AACR2026Co-authorLate-breaking - The TIME trial: Phase II randomized controlled trial of time-of-day–specified nivolumab and ipilimumab for advanced melanoma.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 3 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
Clinical cancer research
Article2024 - Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy.
Journal for immunotherapy of cancer
Article2020 - Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
Pediatric blood & cancer
Clinical Trial2020
Most-cited works
by citation count (OpenAlex)- 01
- 02Matrix metalloproteinases: their functional role in lung cancerArticle206 citations2017
- 03Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapyArticle183 citations2020
- 04
- 05The Abscopal Effect: A Review of Pre-Clinical and Clinical AdvancesArticle169 citations2021
Network
Updated 3 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 3 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
- PhD in immunology
Saint Louis University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
Editorial & leadership roles
journal and society appointments- Assistant Director for Basic Research and Shared Resources
Winship Cancer Institute of Emory University
2025verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - Member
NCI Experimental Therapeutics Clinical Trials Network Skin Committee
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗ - Member
ECOG-ACRIN Radiation Committee
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →astro.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
Secondary affiliations
appointments beyond the home institution- Faculty member
Cancer Biology Graduate Program, Emory's Laney Graduate School
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →winshipcancer.emory.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Nanette Wenger, MD
Emory University School of Medicine
Robert Guyton, MD
Emory University School of Medicine
Arshed Quyyumi, MD
Emory University School of Medicine
Guillermo Umpierrez, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
David Reardon, MD
Dana-Farber Cancer Institute
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center